PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pahenu2 mice

This publication has 40 references indexed in Scilit:

• Oxidative stress in patients with phenylketonuria
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2005
• Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase
  The FASEB Journal, 2004
• Plasma thiols and their determinants in phenylketonuria
  European Journal of Clinical Nutrition, 2003
• Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors
  Gene Therapy, 2001
• Role of Free Radicals in the Neurodegenerative Diseases
  Drugs & Aging, 2001
• Context Dependence of Different Modules for Posttranscriptional Enhancement of Gene Expression from Retroviral Vectors
  Molecular Therapy, 2000
• Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain
  Gene Therapy, 2000
• Characterization of Mutations at the Mouse Phenylalanine Hydroxylase Locus
  Genomics, 1997
• A study of cerebellar and cerebral cortical degeneration in Miniature Poodle pups with emphasis on the ultrastructure of Purkinje cell changes
  Acta Neuropathologica, 1988
• NATURAL HISTORY OF PHENYLKETONURIA AND INFLUENCE OF EARLY TREATMENT
  The Lancet, 1974